Delivery Order SPE2DB22D3501-SPE2DB25FWM68
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 12, 2025, for $17,709.48 under a firm fixed price contract type. The award covers the supply of Xeljanz XR 11 mg tablets in quantities of 30 units, a prescription medication used to treat inflammatory conditions. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $7,573.25 to supply 11 mg Xeljanz XR tablets. As the prime contractor, Amerisourcebergen will deliver 30 units of the specified pharmaceutical product to the place of performance in Conshohocken, Pennsylvania by November 16, 2023. This order was awarded against an indefinite delivery contract held by Amerisourcebergen with no set-aside designation...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency for XELJANZ XR 11 mg tablets in 30-count unit doses, valued at $18,565.52 under a firm fixed price contract type. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, carries no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $5,806.62 by the Defense Logistics Agency (DLA) for the supply of XELJANZ XR 11 mg tablets in quantities of 30 units per package. This is a firm fixed-price, competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement requirements through open competition. The contract was awarded on May 28, 2025, with an ultimate completion date of May 29, 2025, and...
- The Defense Logistics Agency awarded a delivery order valued at $24,639.34 to AmerisourceBergen Drug Corp for the supply of 60 units of Xeljanz 5 mg tablets. This competitive award, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, utilizes firm fixed pricing and carries no set-aside designation. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $17,873.07 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 8, 2025, for XELJANZ XR 11 mg tablets (30-count packages). The award, which carries an ultimate completion date of August 11, 2025, represents a non-set-aside competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Xeljanz XR 11 mg tablets, valued at $21,502.80. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA, which serves as the primary vehicle for Amerisourcebergen to provide a range of pharmaceutical products and medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,599.24 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of XELJANZ XR 11 MG tablets in quantities of 30 units. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by July 22, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 4, 2025, for Xeljanz 5 mg tablets (60-count units) under a firm fixed price contract with a ceiling value of $19,446.19. This is a non-set-aside competitive award funded by the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of September 5, 2025. The place of performance is located in Conshohocken, Pennsylvania, where the vendor maintains its...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 3, 2025, for XELJANZ XR 11 mg tablets in 30-count units, with a ceiling value of $10,286.16. This firm fixed price, non-set-aside contract is scheduled for completion by September 4, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...